Gene · 51428
Papers1,824
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,824
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia. | NPJ Precis Oncol | 2024 | 39256524 | PubTator, text mining | PubMed |
| Acetylcytidine modification of DDX41 and ZNF746 by N-acetyltransferase 10 contributes to chemoresistance of melanoma. | Front Oncol | 2024 | 39246323 | PubTator, text mining | PubMed |
| Advances in pathogenesis research and challenges in treatment development for acute myeloid leukemia. | Int J Hematol | 2024 | 39225969 | PubTator, text mining | PubMed |
| Multifunctional role of DEAD-box helicase 41 in innate immunity, hematopoiesis and disease. | Front Immunol | 2024 | 39185415 | PubTator, text mining | PubMed |
| Molecular pathophysiology of germline mutations in acute myeloid leukemia. | Int J Hematol | 2024 | 39150677 | PubTator, text mining | PubMed |
| How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms. | Hemasphere | 2024 | 39139355 | PubTator, text mining | PubMed |
| Human brain organoids containing microglia that have arisen innately adapt to a β-amyloid challenge better than those in which microglia are integrated by co-culture. | Stem Cell Res Ther | 2024 | 39135132 | PubTator, text mining | PubMed |
| Targeting the hydrophobic region of pyroglutamate-modified amyloid-β by tyrocidine A prevents its nucleation-aggregation process and its "catalytic effect" on the Aβs aggregation. | J Biochem Mol Toxicol | 2024 | 39132781 | PubTator, text mining | PubMed |
| Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia. | Cancer Rep (Hoboken) | 2024 | 39118233 | PubTator, text mining | PubMed |
| Peripheral Blood and Bone Marrow Findings in Treatment-Naive Patients With Cytopenia(s)/Myeloid Neoplasms Harboring Both a Germline and a Somatic DDX41 Mutation. | Appl Immunohistochem Mol Morphol | 2024 | 39046192 | PubTator, text mining | PubMed |
| Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges. | Stem Cell Res Ther | 2024 | 39026343 | PubTator, text mining | PubMed |
| Turn-on protein switches for controlling actin binding in cells. | Nat Commun | 2024 | 38992021 | PubTator, text mining | PubMed |
| Unconventional posttranslational modification in innate immunity. | Cell Mol Life Sci | 2024 | 38970666 | PubTator, text mining | PubMed |
| DDX41 and its unique contribution to myeloid leukemogenesis. | Oncotarget | 2024 | 38953908 | PubTator, text mining | PubMed |
| Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry? | Cytometry B Clin Cytom | 2024 | 38940080 | PubTator, text mining | PubMed |
| DDX41 haploinsufficiency causes inefficient hematopoiesis under stress and cooperates with p53 mutations to cause hematologic malignancy. | Leukemia | 2024 | 38937548 | PubTator, text mining | PubMed |
Discovery and Characterization of the ddx41 Gene in Atlantic Salmon: Evolutionary Implications, Structural Functions, and Innate Immune Responses to Piscirickettsia salmonis and Renibacterium salmoninarum Infections. | Int J Mol Sci | 2024 | 38928053 | PubTator, text mining | PubMed |
| Apo and Aβ46-bound γ-secretase structures provide insights into amyloid-β processing by the APH-1B isoform. | Nat Commun | 2024 | 38802343 | PubTator, text mining | PubMed |
| SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period. | Diagnostics (Basel) | 2024 | 38786337 | PubTator, text mining | PubMed |
| Biological relevance of alternative splicing in hematologic malignancies. | Mol Med | 2024 | 38760666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51428/papers?page=7